Vanguard Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.6M Buy
1,810,165
+61,237
+4% +$797K ﹤0.01% 2484
2025
Q1
$18.5M Buy
1,748,928
+64,367
+4% +$682K ﹤0.01% 2538
2024
Q4
$28.6M Buy
1,684,561
+107,635
+7% +$1.83M ﹤0.01% 2414
2024
Q3
$36.6M Buy
1,576,926
+192,182
+14% +$4.46M ﹤0.01% 2313
2024
Q2
$33.7M Sell
1,384,744
-3,150
-0.2% -$76.7K ﹤0.01% 2309
2024
Q1
$46.9M Sell
1,387,894
-70,486
-5% -$2.38M ﹤0.01% 2202
2023
Q4
$46M Buy
1,458,380
+51,537
+4% +$1.62M ﹤0.01% 2223
2023
Q3
$35.9M Sell
1,406,843
-221,573
-14% -$5.66M ﹤0.01% 2285
2023
Q2
$46.7M Buy
1,628,416
+163,070
+11% +$4.68M ﹤0.01% 2216
2023
Q1
$35.1M Buy
1,465,346
+14,921
+1% +$358K ﹤0.01% 2340
2022
Q4
$24.6M Buy
1,450,425
+113,607
+8% +$1.93M ﹤0.01% 2528
2022
Q3
$19.8M Buy
1,336,818
+143,162
+12% +$2.12M ﹤0.01% 2627
2022
Q2
$18.8M Buy
1,193,656
+40,143
+3% +$632K ﹤0.01% 2669
2022
Q1
$31.1M Buy
1,153,513
+6,291
+0.5% +$170K ﹤0.01% 2545
2021
Q4
$42.5M Buy
1,147,222
+33,271
+3% +$1.23M ﹤0.01% 2450
2021
Q3
$53.2M Sell
1,113,951
-65,890
-6% -$3.15M ﹤0.01% 2326
2021
Q2
$39.9M Sell
1,179,841
-17,539
-1% -$594K ﹤0.01% 2487
2021
Q1
$49.5M Buy
1,197,380
+14,998
+1% +$619K ﹤0.01% 2324
2020
Q4
$51.3M Buy
1,182,382
+145,205
+14% +$6.3M ﹤0.01% 2189
2020
Q3
$44.5M Buy
1,037,177
+166,242
+19% +$7.13M ﹤0.01% 2074
2020
Q2
$40.7M Buy
870,935
+727,354
+507% +$34M ﹤0.01% 2104
2020
Q1
$1.95M Buy
143,581
+19,700
+16% +$268K ﹤0.01% 3321
2019
Q4
$1.35M Hold
123,881
﹤0.01% 3554
2019
Q3
$1.27M Buy
+123,881
New +$1.27M ﹤0.01% 3579